Highlights
1 patent
About
Developing Oral Delivery of Injectable Drugs
I2O Pharma specializes in developing oral versions of injectable drugs, using technology licensed from the Hebrew University of Jerusalem. The company is now planning human trials. I2O Pharma is supported byAurum Ventures MKI. The company is inactive and the updating process will be stopped since 11/2018.
Identity
| Name | I2O Pharma |
|---|---|
| Slug | i2o-pharma |
| Type / kind | startup |
| Crunchbase ID | i2o-pharma |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6fg-IIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2018 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat Gan |
| HQ address | Derech Aba Hillel 16, Ramat Gan, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharmaceuticalsdrug-deliveryoral-drugspharma-companies
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}